Recommendation for Duration of DAPT in Patients With

Management of ST-Elevation Myocardial Infarction, 2014
AHA/ACC Guideline for the Management of Patients With
Non–ST-Elevation Acute Coronary Syndromes, and 2014
ACC/AHA Guideline on Perioperative Cardiovascular
Evaluation and Management of Patients Undergoing
Noncardiac Surgery
by Glenn N. Levine, Eric R. Bates, John A. Bittl, Ralph G. Brindis, Stephan D. Fihn,
Lee A. Fleisher, Christopher B. Granger, Richard A. Lange, Michael J. Mack, Laura
Mauri, Roxana Mehran, Debabrata Mukherjee, L. Kristin Newby, Patrick T. O’Gara,
Marc S. Sabatine, Peter K. Smith, and Sidney C. Smith
Circulation
Volume 134(10):e123-e155
September 6, 2016
Copyright © American Heart Association, Inc. All rights reserved.
Applying Class of Recommendation and Level of Evidence to Clinical Strategies, Interventions,
Treatments, or Diagnostic Testing in Patient Care* (Updated August 2015).
Glenn N. Levine et al. Circulation. 2016;134:e123-e155
Copyright © American Heart Association, Inc. All rights reserved.
Master treatment algorithm for duration of P2Y12 inhibitor therapy in patients with CAD treated
with DAPT. Colors correspond to Class of Recommendation in Table 1.
Glenn N. Levine et al. Circulation. 2016;134:e123-e155
Copyright © American Heart Association, Inc. All rights reserved.
Recommendations for Specific P2Y12 Inhibitors.
Glenn N. Levine et al. Circulation. 2016;134:e123-e155
Copyright © American Heart Association, Inc. All rights reserved.
Recommendation for Aspirin Dosing in Patients Treated With DAPT.
Glenn N. Levine et al. Circulation. 2016;134:e123-e155
Copyright © American Heart Association, Inc. All rights reserved.
Recommendations for Duration of DAPT in Patients With SIHD Treated With PCI.
Glenn N. Levine et al. Circulation. 2016;134:e123-e155
Copyright © American Heart Association, Inc. All rights reserved.
Recommendations for Duration of DAPT in Patients With ACS Treated With PCI.
Glenn N. Levine et al. Circulation. 2016;134:e123-e155
Copyright © American Heart Association, Inc. All rights reserved.
Treatment algorithm for duration of P2Y12 inhibitor therapy in patients treated with PCI. Colors
correspond to Class of Recommendation in Table 1.
Glenn N. Levine et al. Circulation. 2016;134:e123-e155
Copyright © American Heart Association, Inc. All rights reserved.
Recommendations for Duration of DAPT in Patients Undergoing CABG.
Glenn N. Levine et al. Circulation. 2016;134:e123-e155
Copyright © American Heart Association, Inc. All rights reserved.
Treatment algorithm for management and duration of P2Y12 inhibitor therapy in patients
undergoing CABG. Colors correspond to Class of Recommendation in Table 1.
Glenn N. Levine et al. Circulation. 2016;134:e123-e155
Copyright © American Heart Association, Inc. All rights reserved.
Recommendations for Duration of DAPT in Patients With SIHD.
Glenn N. Levine et al. Circulation. 2016;134:e123-e155
Copyright © American Heart Association, Inc. All rights reserved.
Treatment algorithm for duration of P2Y12 inhibitor therapy in patients with SIHD (without ACS
within the past several years).
Glenn N. Levine et al. Circulation. 2016;134:e123-e155
Copyright © American Heart Association, Inc. All rights reserved.
Recommendations for Duration of DAPT in Patients With ACS Treated with Medical Therapy
Alone.
Glenn N. Levine et al. Circulation. 2016;134:e123-e155
Copyright © American Heart Association, Inc. All rights reserved.
Recommendations for Duration of DAPT in Patients With STEMI Treated With Fibrinolytic
Therapy.
Glenn N. Levine et al. Circulation. 2016;134:e123-e155
Copyright © American Heart Association, Inc. All rights reserved.
Recommendations for Duration of DAPT in Patients With ACS Treated With PCI.
Glenn N. Levine et al. Circulation. 2016;134:e123-e155
Copyright © American Heart Association, Inc. All rights reserved.
Recommendation for Duration of DAPT in Patients With ACS Treated With CABG.
Glenn N. Levine et al. Circulation. 2016;134:e123-e155
Copyright © American Heart Association, Inc. All rights reserved.
Treatment algorithm for duration of P2Y12 inhibitor therapy in patients with recent ACS (NSTEACS or STEMI).
Glenn N. Levine et al. Circulation. 2016;134:e123-e155
Copyright © American Heart Association, Inc. All rights reserved.
Recommendations for Perioperative Management–Timing of Elective Noncardiac Surgery in
Patients Treated With PCI and DAPT.
Glenn N. Levine et al. Circulation. 2016;134:e123-e155
Copyright © American Heart Association, Inc. All rights reserved.
Treatment algorithm for the timing of elective noncardiac surgery in patients with coronary
stents.
Glenn N. Levine et al. Circulation. 2016;134:e123-e155
Copyright © American Heart Association, Inc. All rights reserved.